$HLTHQ
Cue Health Inc.

2023 Q4 Form 10-Q Financial Statement

#000162894523000175 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $18.80M $17.48M $146.8M
YoY Change -87.19% -74.89% -23.75%
Cost Of Revenue $35.74M $22.18M $90.78M
YoY Change -60.63% -56.16% -11.69%
Gross Profit -$16.94M -$4.703M $55.99M
YoY Change -130.26% -124.76% -37.58%
Gross Profit Margin -90.14% -26.91% 38.15%
Selling, General & Admin $16.09M $22.90M $38.47M
YoY Change -58.17% -47.66% -13.84%
% of Gross Profit 68.7%
Research & Development $32.25M $37.10M $56.15M
YoY Change -42.57% -12.73% 159.0%
% of Gross Profit 100.28%
Depreciation & Amortization $18.29M $11.20M $11.95M
YoY Change 52.98% 34.94% 85.89%
% of Gross Profit 21.35%
Operating Expenses $48.34M $60.00M $94.62M
YoY Change -48.91% -30.45% 42.65%
Operating Profit -$65.28M -$64.71M -$38.62M
YoY Change 69.02% -4.02% -265.19%
Interest Expense $5.896M -$304.0K -$232.0K
YoY Change -2641.38% -12.14% 307.02%
% of Operating Profit
Other Income/Expense, Net -$5.363M $1.833M $2.035M
YoY Change -363.54% 348.17% 599.31%
Pretax Income -$148.4M -$42.24M -$36.82M
YoY Change 302.95% -37.29% -255.92%
Income Tax $60.00K $4.733M -$5.315M
% Of Pretax Income
Net Earnings -$148.4M -$46.97M -$31.51M
YoY Change 371.12% -29.16% -192.04%
Net Earnings / Revenue -789.62% -268.75% -21.47%
Basic Earnings Per Share -$0.31
Diluted Earnings Per Share -$0.96 -$0.31 -$0.21
COMMON SHARES
Basic Shares Outstanding 154.6M shares 153.5M shares 149.4M shares
Diluted Shares Outstanding 153.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.89M $111.5M $241.5M
YoY Change -66.51% -63.42% -41.07%
Cash & Equivalents $80.89M $111.5M $241.5M
Short-Term Investments
Other Short-Term Assets $4.803M $5.248M $12.13M
YoY Change -60.42% -60.96% 62.96%
Inventory $14.04M $63.56M $82.21M
Prepaid Expenses $8.479M $9.862M $15.73M
Receivables $1.352M $1.320M $18.75M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $110.4M $192.2M $371.2M
YoY Change -70.27% -63.16% -44.61%
LONG-TERM ASSETS
Property, Plant & Equipment $150.6M $247.1M $274.6M
YoY Change -45.15% -11.59% 6.88%
Goodwill
YoY Change
Intangibles $19.64M $21.54M $16.87M
YoY Change 16.46%
Long-Term Investments
YoY Change
Other Assets $2.893M $3.735M $6.528M
YoY Change -55.68% -50.71% 20.11%
Total Long-Term Assets $229.4M $300.1M $323.4M
YoY Change -29.06% -1.03% 19.77%
TOTAL ASSETS
Total Short-Term Assets $110.4M $192.2M $371.2M
Total Long-Term Assets $229.4M $300.1M $323.4M
Total Assets $339.8M $492.3M $694.6M
YoY Change -51.08% -40.33% -26.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.705M $11.11M $7.150M
YoY Change 7.76% -65.84% -80.78%
Accrued Expenses $34.44M $45.03M $60.12M
YoY Change -42.71% -18.81% 64.05%
Deferred Revenue $162.0K $623.0K $1.566M
YoY Change -89.66% -99.27% -98.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.157M $1.646M $2.362M
YoY Change -51.02% -36.23%
Total Short-Term Liabilities $43.47M $58.41M $71.20M
YoY Change -38.95% -66.71% -57.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $849.0K
YoY Change -100.0% -100.0% -74.04%
Other Long-Term Liabilities $4.429M $2.091M $1.997M
YoY Change 121.78% -45.38% -68.58%
Total Long-Term Liabilities $4.429M $2.091M $1.997M
YoY Change 121.78% -45.38% -68.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.47M $58.41M $71.20M
Total Long-Term Liabilities $4.429M $2.091M $1.997M
Total Liabilities $89.54M $103.5M $118.1M
YoY Change -24.18% -55.99% -49.39%
SHAREHOLDERS EQUITY
Retained Earnings -$591.5M -$443.1M -$218.1M
YoY Change 171.21% 137.5% 808.07%
Common Stock $2.000K $2.000K $1.000K
YoY Change 100.0% 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $250.3M $388.8M $576.5M
YoY Change
Total Liabilities & Shareholders Equity $339.8M $492.3M $694.6M
YoY Change -51.08% -40.33% -26.11%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$148.4M -$46.97M -$31.51M
YoY Change 371.12% -29.16% -192.04%
Depreciation, Depletion And Amortization $18.29M $11.20M $11.95M
YoY Change 52.98% 34.94% 85.89%
Cash From Operating Activities -$28.72M -$12.54M -$51.70M
YoY Change -44.45% -68.58% -684.25%
INVESTING ACTIVITIES
Capital Expenditures $1.834M $3.655M $10.09M
YoY Change -81.81% -120.01% -126.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.834M -$3.655M -$10.09M
YoY Change -81.81% -79.99% -73.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -901.0K -1.873M
YoY Change -99.47% 204.39% -69.65%
NET CHANGE
Cash From Operating Activities -28.72M -12.54M -51.70M
Cash From Investing Activities -1.834M -3.655M -10.09M
Cash From Financing Activities -10.00K -901.0K -1.873M
Net Change In Cash -30.57M -17.10M -63.66M
YoY Change -51.99% -70.76% 82.51%
FREE CASH FLOW
Cash From Operating Activities -$28.72M -$12.54M -$51.70M
Capital Expenditures $1.834M $3.655M $10.09M
Free Cash Flow -$30.56M -$16.20M -$61.78M
YoY Change -50.55% -25.17% -233.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-162550000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148582721 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152226999 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147443196 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153699408 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148582721 shares
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Cue Health Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1562193
dei Entity Address Address Line1
EntityAddressAddressLine1
4980 Carroll Canyon Rd.
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
800000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18751000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
371153000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
25436000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
189275000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85321000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16867000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6528000 usd
CY2022Q4 us-gaap Assets
Assets
694580000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2362000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71195000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44045000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
849000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1997000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
118086000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-67413000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-245948000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-167028000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-346000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-815000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-413000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1833000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42237000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4733000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-46970000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Net Income Loss
NetIncomeLoss
-162550000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001628945
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
412-8151
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
HLTH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154632057 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111454000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
241530000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
800000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1320000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
63555000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
82210000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9862000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15728000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5248000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
12134000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
192239000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
27640000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
166311000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80829000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21539000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3735000 usd
CY2023Q3 us-gaap Assets
Assets
492293000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11109000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7150000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
39920000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
52378000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
623000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1566000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5109000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7739000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1646000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
58407000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42961000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2091000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
103459000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154601335 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154601335 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150406014 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150406014 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
831938000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
794567000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-443106000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218074000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
388834000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576494000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
492293000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
694580000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17477000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69589000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52138000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336699000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7051000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18129000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26358000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69268000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37103000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42516000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118372000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
115303000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15848000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25625000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47489000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
77946000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
137000 usd
us-gaap Restructuring Charges
RestructuringCharges
14518000 usd
us-gaap Restructuring Charges
RestructuringCharges
2020000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
82182000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
137002000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
298086000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
503727000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-64705000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-304000 usd
CY2023Q3 hlth Tax Credits Income
TaxCreditsIncome
20939000 usd
CY2022Q3 hlth Tax Credits Income
TaxCreditsIncome
0 usd
hlth Tax Credits Income
TaxCreditsIncome
20939000 usd
hlth Tax Credits Income
TaxCreditsIncome
0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
409000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5525000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
458000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67350000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-220299000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-166983000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1047000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4733000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4433000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66303000 usd
us-gaap Net Income Loss
NetIncomeLoss
-225032000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153699408 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152226999 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147443196 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
423177000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
825973 shares
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
259000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
319000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12687000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-46970000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
388834000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
640373000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
147463 shares
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1468000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1268000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15690000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66303000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
589960000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576494000 usd
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
1299053 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
372000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1585000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38597000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
12000 usd
us-gaap Net Income Loss
NetIncomeLoss
-225032000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
388834000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
706750000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
147463 shares
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2180000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3021000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4557000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-130076000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-117722000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242330000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1980000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4735000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48515000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
589960000 usd
us-gaap Net Income Loss
NetIncomeLoss
-225032000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162550000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37992000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32989000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-308000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1729000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
38597000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
48515000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7186000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6215000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3478000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
65000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
137000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
202000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
319000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-17739000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-78081000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16451000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44921000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9512000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7151000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2591000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1912000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13092000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13401000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6358000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-11331000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-943000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2734000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6408000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12996000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109090000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60219000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7800000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43179000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
10165000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
9767000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17965000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52946000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
113000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1980000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1584000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4735000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
372000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
977000 usd
hlth Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs
PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts
0 usd
hlth Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs
PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts
599000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
292000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1630000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
423710000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112254000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
305988000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111454000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
304654000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
800000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1334000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112254000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
305988000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2611000 usd
hlth Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
0 usd
hlth Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
50000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2594000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4313000 usd
hlth Software Development Costs Incurred But Not Yet Paid
SoftwareDevelopmentCostsIncurredButNotYetPaid
115000 usd
hlth Software Development Costs Incurred But Not Yet Paid
SoftwareDevelopmentCostsIncurredButNotYetPaid
995000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to revenue recognition, net accounts receivable, equity-based compensation expense, product warranty reserve, the usage and recoverability of its inventories, long-lived assets, intangible assets and net deferred tax assets (net of related valuation allowance). The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-443100000 usd
CY2023Q3 hlth Tax Credits Income
TaxCreditsIncome
20900000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2003000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2027000 usd
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
6100000 usd
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
0 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
300000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
300000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1566000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
92448000 usd
hlth Contract With Customer Liability Unearned Revenue From Cash Received During The Period
ContractWithCustomerLiabilityUnearnedRevenueFromCashReceivedDuringThePeriod
623000 usd
hlth Contract With Customer Liability Unearned Revenue From Cash Received During The Period
ContractWithCustomerLiabilityUnearnedRevenueFromCashReceivedDuringThePeriod
2734000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1566000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
623000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
95182000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2311000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
318000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-308000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1729000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
20000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
77819000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
80968000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
9136000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
14305000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
39182000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
37867000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
34942000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
25494000 usd
CY2023Q3 hlth Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
91195000 usd
CY2022Q4 hlth Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
107646000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
27640000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
25436000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
63555000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
82210000 usd
CY2023Q3 hlth Prepaid Expense Excluding Prepaid Inventory Current
PrepaidExpenseExcludingPrepaidInventoryCurrent
6409000 usd
CY2022Q4 hlth Prepaid Expense Excluding Prepaid Inventory Current
PrepaidExpenseExcludingPrepaidInventoryCurrent
11523000 usd
CY2023Q3 hlth Prepaid Inventory Current
PrepaidInventoryCurrent
3453000 usd
CY2022Q4 hlth Prepaid Inventory Current
PrepaidInventoryCurrent
4205000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9862000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15728000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
281651000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
272230000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
115340000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
82955000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
166311000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
189275000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
11200000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
8300000 usd
us-gaap Depreciation
Depreciation
32400000 usd
us-gaap Depreciation
Depreciation
28600000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5400000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7300000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
32871000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11332000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21539000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22591000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5724000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16867000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2400000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80829000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85321000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5437000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7264000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5109000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7739000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1646000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2362000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42961000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44045000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
849000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3197000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3192000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
9198000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
8749000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
896000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
819000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2127000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2098000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
24000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
43000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
65000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
137000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
4117000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
4054000 usd
us-gaap Lease Cost
LeaseCost
11390000 usd
us-gaap Lease Cost
LeaseCost
10984000 usd
CY2023Q3 hlth Accrued Liabilities Purchases Current
AccruedLiabilitiesPurchasesCurrent
1127000 usd
CY2022Q4 hlth Accrued Liabilities Purchases Current
AccruedLiabilitiesPurchasesCurrent
4488000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17428000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26350000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6070000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5553000 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1147000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1361000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2966000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
6660000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2838000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
107000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 usd
CY2023Q3 hlth Accrued Purchase Commitment Loss Current
AccruedPurchaseCommitmentLossCurrent
8237000 usd
CY2022Q4 hlth Accrued Purchase Commitment Loss Current
AccruedPurchaseCommitmentLossCurrent
7966000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
39920000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
52378000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7102853 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.92
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3473387 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.15
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
169515 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1084592 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
355010 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.27
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8967123 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5880224 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8967123 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-46970000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66303000 usd
us-gaap Net Income Loss
NetIncomeLoss
-225032000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162550000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153699408 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153699408 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148582721 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148582721 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152226999 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152226999 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147443196 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147443196 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30280827 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26722799 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30280827 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26722799 shares
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.112
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.016
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.027
hlth Standard Product Warranty Term
StandardProductWarrantyTerm
P12M
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6660000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1315000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5009000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2966000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
14518000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
13862000 usd
us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
-549000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
107000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
800000 usd
CY2023Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
24200000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Trd Arr Ind Title
TrdArrIndTitle
Chief Product Officer

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
hlth-20230930_pre.xml Edgar Link unprocessable
0001628945-23-000175-index-headers.html Edgar Link pending
0001628945-23-000175-index.html Edgar Link pending
0001628945-23-000175.txt Edgar Link pending
0001628945-23-000175-xbrl.zip Edgar Link pending
exhibit31109302310-q.htm Edgar Link pending
exhibit31209302310-q.htm Edgar Link pending
exhibit32109302310-q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hlth-20230930.htm Edgar Link pending
hlth-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
hlth-20230930_def.xml Edgar Link unprocessable
hlth-20230930_cal.xml Edgar Link unprocessable
hlth-20230930_lab.xml Edgar Link unprocessable
hlth-20230930_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending